A year after the first samRNA vaccine approval, experts say others are likely to face scientific and regulatory hurdles.

Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...

The discovery of the first mRNA-stabilizing substance could pave the way for groundbreaking advancements in the development ...

We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts. In this article, we are going to take a ...

At IDWeek 2024, Moderna presented interim results from an ongoing Phase I/II dose-ranging trial for mRNA-1403, a vaccine ...

On Monday, Moderna Inc (MRNA) stock saw a decline, ending the day at $53.8 which represents a decrease of $-0.30 or -0.55% from the prior close of $54.1. The stock opened at $53.82 and touched a low ...

Study reveals single-chain mRNA vaccines confer 100% protection against lethal mpox challenge in mice, marking a significant ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

Hello Health Rounds Readers! Today we report on a promising animal study of a mRNA vaccine that could one day prevent or ...

Scientists in Australia have found why mRNA vaccines trigger side effects, paving the way for more effective vaccines.

Current cancer treatments typically include surgery, chemotherapy, radiotherapy, and immunotherapy. However, these approaches ...

Learn how the chemical synthesis method for mRNA can accelerate vaccine production, enhancing responses to viral outbreaks ...